Sign up for email alert when new content gets added: Sign up
The Journal of Blood Disorders and Treatment is peer-reviewed, open access, scholarly journal aimed at publishing the latest advancements in the field, enriching our understanding of blood disorders such as: Clotting Disorders, Anemias, Hematologic Malignancies, Coagulopathies, Thrombotic Disorders, Hemoglobinopathies, Lymphoproliferative Disorders, Plasma Cell Disorders,and Immunologic and Genetic Disorders of the blood. The journal offers a platform for dissemination of information on all aspects of blood-related disorders such as prevention, diagnosis, and management of these disorders.
The scope of the journal includes, but is not restricted to diseases such as: Anemia, Neutropenia, Hemophilia, Thalassemia, Antiphospholipid Syndrome,Lupus, Sickle Cell Disease, Leukemia, Lymphoma, Myeloma, Von Willebrand Disease, Autoimmune Lymphoproliferative Syndrome,and Deep Vein Thrombosis. Special emphasis is placed on the treatment and management strategies such as: Thrombolytics, Thrombectomy, Blood Transfusion, Stem Cell Transplantation, Artificial Cells, Blood Substitutes, Recombinant Clotting Factors,Gene Therapy, and Chemo and Radiotherapy.
Authors are invited to publish their findings and opinions in the form of research articles, review articles, short communications, case reports, letters to the editor, guidelines, and techniques on all topics related to blood disorders.
Author(s) can submit their manuscripts through the journal's online submission and tracking system at: https://www.pulsus.com/submissions/blood-disorders-treatment.html or as an e-mail attachment at firstname.lastname@example.org
Fast Editorial Execution and Review Process (FEE-Review Process):
Journal of Blood Disorders and Treatment is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
Articles published in Journal of Blood Disorders and Treatment have been cited by esteemed scholars and scientists all around the world. Journal of Blood Disorders and Treatment has got h-index 2 , which means every article in Journal of Blood Disorders and Treatment has got 2 average citations.
Journal of Blood Disorders and Treatment received 88 citations as per Google Scholar report